Fig. 1

(A) Study schematic and (B) participant inclusion and exclusion flowchart. NAC = neoadjuvant chemotherapy, pCR = pathologic complete response, TNBC = triple-negative breast cancer, HER2 = human epidermal growth factor receptor-2